113 related articles for article (PubMed ID: 34246048)
1. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization.
Yang G; Yuan Z; Ahmed K; Welsh EA; Fulp WJ; Gonzalez RJ; Mullinax JE; Letson D; Bui M; Harrison LB; Scott JG; Torres-Roca JF; Naghavi AO
Transl Oncol; 2021 Oct; 14(10):101165. PubMed ID: 34246048
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy.
Yuan Z; Grass GD; Azizi M; Ahmed KA; Yoder GSJ; Welsh EA; Fulp WJ; Dhillon J; Torres-Roca JF; Giuliano AR; Spiess PE; Johnstone PA
Rep Pract Oncol Radiother; 2019; 24(6):593-599. PubMed ID: 31719799
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.
Ahmed KA; Scott JG; Arrington JA; Naghavi AO; Grass GD; Perez BA; Caudell JJ; Berglund AE; Welsh EA; Eschrich SA; Dilling TJ; Torres-Roca JF
J Thorac Oncol; 2018 Aug; 13(8):1121-1127. PubMed ID: 29733909
[TBL] [Abstract][Full Text] [Related]
4. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
Naghavi AO; Bryant JM; Kim Y; Weygand J; Redler G; Sim AJ; Miller J; Coucoules K; Michael LT; Gloria WE; Yang G; Rosenberg SA; Ahmed K; Bui MM; Henderson-Jackson EB; Lee A; Lee CD; Gonzalez RJ; Feygelman V; Eschrich SA; Scott JG; Torres-Roca J; Latifi K; Parikh N; Costello J
BMC Cancer; 2024 Apr; 24(1):437. PubMed ID: 38594603
[TBL] [Abstract][Full Text] [Related]
5. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA; Liveringhouse CL; Mills MN; Figura NB; Grass GD; Washington IR; Harris EE; Czerniecki BJ; Blumencranz PW; Eschrich SA; Scott JG; Diaz R; Torres-Roca JF
EBioMedicine; 2019 Sep; 47():163-169. PubMed ID: 31416721
[TBL] [Abstract][Full Text] [Related]
6. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
Torres-Roca JF; Fulp WJ; Caudell JJ; Servant N; Bollet MA; van de Vijver M; Naghavi AO; Harris EE; Eschrich SA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):631-8. PubMed ID: 26461005
[TBL] [Abstract][Full Text] [Related]
7. Validation of a radiosensitivity molecular signature in breast cancer.
Eschrich SA; Fulp WJ; Pawitan Y; Foekens JA; Smid M; Martens JW; Echevarria M; Kamath V; Lee JH; Harris EE; Bergh J; Torres-Roca JF
Clin Cancer Res; 2012 Sep; 18(18):5134-43. PubMed ID: 22832933
[TBL] [Abstract][Full Text] [Related]
8. Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy.
Mohammadi H; Prince A; Figura NB; Peacock JS; Fernandez DC; Montejo ME; Chon HS; Wenham RM; Eschrich SA; Torres-Roca JF; Ahmed KA
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):496-502. PubMed ID: 31759077
[TBL] [Abstract][Full Text] [Related]
9. Tumour radiosensitivity is associated with immune activation in solid tumours.
Strom T; Harrison LB; Giuliano AR; Schell MJ; Eschrich SA; Berglund A; Fulp W; Thapa R; Coppola D; Kim S; Frakes J; Foekens J; Mulé JJ; Torres-Roca JF
Eur J Cancer; 2017 Oct; 84():304-314. PubMed ID: 28863385
[TBL] [Abstract][Full Text] [Related]
10. Clinical Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy: A Systematic Review.
Bleaney CW; Abdelaal H; Reardon M; Anandadas C; Hoskin P; Choudhury A; Forker L
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792019
[TBL] [Abstract][Full Text] [Related]
11. Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Chiang CL; Chan KSK; Li H; Ng WT; Chow JCH; Choi HCW; Lam KO; Lee VHF; Ngan RKC; Lee AWM; Eschrich SA; Torres-Roca JF; Wong JWH
Radiother Oncol; 2024 Apr; 196():110287. PubMed ID: 38636709
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.
Scott JG; Sedor G; Ellsworth P; Scarborough JA; Ahmed KA; Oliver DE; Eschrich SA; Kattan MW; Torres-Roca JF
Lancet Oncol; 2021 Sep; 22(9):1221-1229. PubMed ID: 34363761
[TBL] [Abstract][Full Text] [Related]
13. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-beta activity.
Akudugu JM; Bell RS; Catton C; Davis AM; Griffin AM; O'Sullivan B; Waldron JN; Ferguson PC; Wunder JS; Hill RP
Radiother Oncol; 2006 Jan; 78(1):17-26. PubMed ID: 16380182
[TBL] [Abstract][Full Text] [Related]
14. Modeling precision genomic-based radiation dose response in rectal cancer.
Yuan Z; Frazer M; Ahmed KA; Naqvi SMH; Schell MJ; Felder S; Sanchez J; Dessureault S; Imanirad I; Kim RD; Torres-Roca JF; Hoffe SE; Frakes JM
Future Oncol; 2020 Oct; 16(30):2411-2420. PubMed ID: 32686956
[No Abstract] [Full Text] [Related]
15. Exploring breast and prostate cancer RNA-seq derived radiosensitivity with the Genomic Adjusted Radiation Dose (GARD) model.
Nolan B; O'Sullivan B; Golden A
Clin Transl Radiat Oncol; 2022 Sep; 36():127-131. PubMed ID: 36017133
[TBL] [Abstract][Full Text] [Related]
16. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis.
Mistry HB
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):565-570. PubMed ID: 36922240
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Macrophage and Radiosensitivity in Human Primary and Recurrent Glioblastoma: In Silico Analysis with Publicly Available Datasets.
Jang BS; Kim IA
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203505
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.
Strom T; Hoffe SE; Fulp W; Frakes J; Coppola D; Springett GM; Malafa MP; Harris CL; Eschrich SA; Torres-Roca JF; Shridhar R
Radiother Oncol; 2015 Oct; 117(1):159-64. PubMed ID: 26235848
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.
Ahmed KA; Caudell JJ; El-Haddad G; Berglund AE; Welsh EA; Yue B; Hoffe SE; Naghavi AO; Abuodeh YA; Frakes JM; Eschrich SA; Torres-Roca JF
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1399-1404. PubMed ID: 27319288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
